Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

HBV/HDV Coinfection
Christopher Koh, Ben L. Da, Jeffrey S. Glenn
Clinics in Liver Disease (2019) Vol. 23, Iss. 3, pp. 557-572
Open Access | Times Cited: 51

Showing 1-25 of 51 citing articles:

Hepatitis B Virus: Advances in Prevention, Diagnosis, and Therapy
Mindie H. Nguyen, Grace Lai‐Hung Wong, Edward Gane, et al.
Clinical Microbiology Reviews (2020) Vol. 33, Iss. 2
Open Access | Times Cited: 415
Weak Induction of Interferon Expression by Severe Acute Respiratory Syndrome Coronavirus 2 Supports Clinical Trials of Interferon-λ to Treat Early Coronavirus Disease 2019
Thomas R. OʼBrien, David L. Thomas, Sarah S. Jackson, et al.
Clinical Infectious Diseases (2020) Vol. 71, Iss. 6, pp. 1410-1412
Open Access | Times Cited: 96
Advances in Targeting the Innate and Adaptive Immune Systems to Cure Chronic Hepatitis B Virus Infection
Zhongji Meng, Yuanyuan Chen, Mengji Lu
Frontiers in Immunology (2020) Vol. 10
Open Access | Times Cited: 91
Recent advances in polymeric nanoparticles for the treatment of hepatic diseases
Feng Gao, Xuefei Feng, Xinyu Li
Frontiers in Pharmacology (2025) Vol. 16
Open Access | Times Cited: 1
Epitranscriptomic marks: Emerging modulators of RNA virus gene expression
Rachel Netzband, Cara T. Pager
Wiley Interdisciplinary Reviews - RNA (2019) Vol. 11, Iss. 3
Open Access | Times Cited: 59
Innate Immunity, Inflammation, and Intervention in HBV Infection
Ge Yang, Pin Wan, Yaru Zhang, et al.
Viruses (2022) Vol. 14, Iss. 10, pp. 2275-2275
Open Access | Times Cited: 33
Hepatitis B Virus Infection: A Mini Review
Diana Asema Asandem, Selorm Philip Segbefia, Kwadwo Asamoah Kusi, et al.
Viruses (2024) Vol. 16, Iss. 5, pp. 724-724
Open Access | Times Cited: 8
Targeting chronic liver diseases: Molecular markers, drug delivery strategies and future perspectives
Janitha M. Unagolla, Subarna Das, Riley Flanagan, et al.
International Journal of Pharmaceutics (2024) Vol. 660, pp. 124381-124381
Closed Access | Times Cited: 6
Effectiveness of pegylated interferon monotherapy in the treatment of chronic hepatitis D virus infection: A meta-analysis
Aigerim Abdrakhman, Aiymkul Ashimkhanova, Wassim Y. Almawi
Antiviral Research (2020) Vol. 185, pp. 104995-104995
Closed Access | Times Cited: 33
Prevalence of Hepatitis D Virus Antibody Positivity in Chinese Patients with Chronic Hepatitis B Virus Infection
Xieer Liang, Qiaoqiao Chen, Hong Tang, et al.
Journal of Clinical and Translational Hepatology (2025) Vol. 000, Iss. 000, pp. 000-000
Open Access
Clinical and economic value of bulevirtide in the treatment of chronic hepatitis D
Marı́a Buti, José Luís Calleja, Miguel Ángel Rodríguez, et al.
Gastroenterología y Hepatología (English Edition) (2025) Vol. 48, Iss. 3, pp. 502241-502241
Open Access
Telemedicine Hybrid Care Models in Gastroenterology Outpatient Care: Results from a German Tertiary Center
Nada Abedin, Christian Kilbinger, Alexander Queck, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 7, pp. 2471-2471
Open Access
Molecular epidemiology and clinical characteristics of hepatitis D virus infection in Canada
Carla Osiowy, Ken Swidinsky, Sarah Haylock‐Jacobs, et al.
JHEP Reports (2022) Vol. 4, Iss. 5, pp. 100461-100461
Open Access | Times Cited: 17
Hepatitis B virus/hepatitis D virus epidemiology: Changes over time and possible future influence of the SARS-CoV-2 pandemic
Caterina Sagnelli, Mariantonietta Pisaturo, Caterina Curatolo, et al.
World Journal of Gastroenterology (2021) Vol. 27, Iss. 42, pp. 7271-7284
Open Access | Times Cited: 20
HepG2BD: A Novel and Versatile Cell Line with Inducible HDV Replication and Constitutive HBV Expression
Matthieu Blanchet, Léna Angelo, Yasmine Tétreault, et al.
Viruses (2024) Vol. 16, Iss. 4, pp. 532-532
Open Access | Times Cited: 2
Clinical and economic value of bulevirtide in the treatment of chronic hepatitis D
Marı́a Buti, José Luís Calleja, Miguel Ángel Rodríguez, et al.
Gastroenterología y Hepatología (2024), pp. 502241-502241
Open Access | Times Cited: 2
Hepatitis B and D in the Pacific Islands of Kiribati
Kathy Merlock Jackson, Rosemary Tekoaua, Thomas Holgate, et al.
Journal of Clinical Virology (2020) Vol. 129, pp. 104527-104527
Closed Access | Times Cited: 15
Review of Lambda Interferons in Hepatitis B Virus Infection: Outcomes and Therapeutic Strategies
Laura A. Novotny, J.G. Evans, Lishan Su, et al.
Viruses (2021) Vol. 13, Iss. 6, pp. 1090-1090
Open Access | Times Cited: 13
A changing landscape: Tracking and analysis of the international HDV epidemiology 1999–2020
Braden S. Fallon, Elaine M. Cooke, Matthew C. Hesterman, et al.
PLOS Global Public Health (2023) Vol. 3, Iss. 4, pp. e0000790-e0000790
Open Access | Times Cited: 5
Digital Droplet PCR for Detection and Quantitation of Hepatitis Delta Virus
Ling Xu, Xiangying Zhang, Yaling Cao, et al.
Clinical and Translational Gastroenterology (2022) Vol. 13, Iss. 7, pp. e00509-e00509
Open Access | Times Cited: 8
HERACLIS‐HDV cohort for the factors of underdiagnosis and prevalence of hepatitis D virus infection in HBsAg‐positive patients
George Papatheodoridis, Konstantinos Mimidis, Spilios Manolakopoulos, et al.
Liver International (2023) Vol. 43, Iss. 9, pp. 1879-1889
Open Access | Times Cited: 4
GCRV NS38 counteracts SVCV proliferation by intracellular antagonization during co-infection
Zhuo-Cong Li, Long-Feng Lu, Can Zhang, et al.
Virologica Sinica (2022) Vol. 38, Iss. 1, pp. 142-156
Open Access | Times Cited: 7
Hepatitis delta virus interacts with splicing factor SF3B155 and alters pre‐mRNA splicing of cell cycle control genes
João Paulo Tavanez, R. Caetano, Cristina Branco, et al.
FEBS Journal (2020) Vol. 287, Iss. 17, pp. 3719-3732
Open Access | Times Cited: 9
Current status of hepatitis delta
Μargarita Papatheodoridi, George Papatheodoridis
Current Opinion in Pharmacology (2021) Vol. 58, pp. 62-67
Closed Access | Times Cited: 9
Sequence diversity of hepatitis D virus in Mongolia
Battur Magvan, Anne Alina Kloeble, Johannes Ptok, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top